Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | EVP Gen'l Counsel & Secretary | August 20, 2026 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,417 |
Reported balance
After 2026-08-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-20 · Tax withholding · Disposed 450 · Balance 24,417 F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2: Includes 17,330 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,870 shares will vest on November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.
F2: Includes 17,330 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,870 shares will vest on November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 24, 2026 23:07 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | Tax withholdingCommon Stock | 450 | $78.00 | $35,100.00 |
DisclosureSEC source: 0001193125-26-363890 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,417 F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting. F2 · balance_after: Includes 17,330 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,870 shares will vest on November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:28 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 3,000 | $81.64 | $244,920.00 |
DisclosureSEC source: 0001193125-26-098618 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,867 F1 · balance_after: Includes 21,070 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:21 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072647 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,867 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 quarterly installments of 624 shares vesting beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each year 2026, 2027, 2028 and 2029 and 640 shares vesting on March 6, 2030, if he still employed by the Company as of those dates. F2 · balance_after: Includes 22,624 (including the awards mentioned in note 1) which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,554 shares will vest on March 6, 2026, 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027 and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028 and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2028 and November 20, 2029 and the final 640 shares will vest on March 6, 2030. Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 21:30 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | Disposition to issuerCommon Stock | 2,000 | $84.79 | $169,580.00 |
DisclosureSEC source: 0000950170-25-110193 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,867 F1 · balance_after: Includes 15,726 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,551 shares on each of August 20, 2025, and November 20, 2025, 1,554 shares on March 6, 2026, 1,246 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026,1,252 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 01:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 8,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028170 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,867 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments of 506 shares vesting on each of May 20, August 20, November 20 and March 6 in each year 2025, 2026, 2027 and 2028, with the final 510 shares vesting on March 6, 2029, if he is employed by the Company on those dates. F2 · balance_after: Includes the shares noted in footnote 1 and 9,177 shares described in next sentences. On February 24, 2025, the issuer and the reporting person mutually agreed to amend the vesting terms of the outstanding awards. Per the amendment, of the total outstanding unvested shares of 9,177, 1,045 will vest on May 20, 2025, August 20, 2025 and November 20, 2025, 1,048 will vest on March 6, 2026, 740 will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 746 will vest on March 6, 2027, 506 will vest on each of May 20, 2027, August 20, 2027, November 2027 and 510 will vest on March 6, 2028, if he is employed on those dates. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 23:30 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | Disposition to issuerCommon Stock | 1,128 | $98.52 | $111,130.56 |
DisclosureSEC source: 0000950170-24-131187 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,767 F1 · balance_after: Includes 10,417 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,241 shares on January 1, 2025; 1,045 shares on each April 1, 2025, July 1, 2025, and on October 1, 2025; 1,049 shares on January 1, 2026; 740 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 747 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:54 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | Disposition to issuerCommon Stock | 2,111 | $106.34 | $224,483.74 |
DisclosureSEC source: 0000950170-24-061806 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,895 F1 · price: The price reported ($106.34) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $106.03 to $106.78 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 12,895 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,239 shares on each of July 1, 2024 and October 1, 2024; 1,241 shares on January 1, 2025; 1,045 shares on each April 1, 2025, July 1, 2025, and on October 1, 2025; 1,049 shares on January 1, 2026; 740 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 747 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 21:11 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $106.55 | $213,100.00 |
DisclosureSEC source: 0000950170-24-031651 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,006 F1 · price: The price reported is a weighted average price ($106.55). The shares were sold in multiple transactions at prices ranging from $106.55 to $106.71 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 14,134 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,239 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 1,241 shares on January 1, 2025; 1,045 shares on each of April 1, 2025, July 1, 2025, October 1, 2025; 1,049 shares on January 1, 2026; 740 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 747 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| February 26, 2024 Filed Feb 29, 2024 01:21 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 8,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-022516 · ownership.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,006 F1 · shares: The 8,100 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 506 shares vesting on April 1, 2024 thereafter 506 shares on April 1, July 1, October 1 and January 1 of each year with the final 510 shares lapsong on Janaury 1, 2028 if he is employed by the Company on those dates. F2 · balance_after: Includes 14,134 shares, inclusive of those shares mentioned in note1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,239 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 1,241 shares on January 1, 2025; 1,045 shares on each of April 1, 2025, July 1, 2025, October 1, 2025; 1,049 shares on January 1, 2026; 740 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 747 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 507 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:31 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $106.60 | $106,600.00 |
DisclosureSEC source: 0001209191-23-046026 · doc4.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,906 F1 · balance_after: Includes 7,970 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 968 shares on October 1, 2023 and on January 1, 2024; 733 shares on each of April 1, 2024, July 1,2024, and October 1, 2024; 734 shares on January 1, 2025; 539 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 542 shares on January 1, 2026, 234 shares on April 1, 2026, July 1, 2026 and October 1, 2026 and 240 shares on January 1, 2027 if he is an employee of the Company on those dates. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 15:20 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 911 | $100.78 | $91,810.58 |
DisclosureSEC source: 0001209191-23-015149 · doc4.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,906 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.71 to $100.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 9,906 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 968 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, and on January 1, 2024; 733 shares on each of April 1, 2024, July 1,2024, and October 1, 2024; 734 shares on January 1, 2025; 539 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 542 shares on January 1, 2026 and 234 shares on April 1, 2026, if he is an employee of the Company on those dates. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 21:31 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012195 · doc4.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,817 F1 · shares: The 3,750 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installments with 234 shares vesting on the first day of each of the succeeding fifteen quarters beginning on April 1, 2023, and with the final 240 shares vesting on January 1, 2027, if he is employed by the Company on those dates. F2 · balance_after: Includes 9,906 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 968 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, and January 1, 2024; 733 shares on each of April 1, 2024, July 1, 2024, and October 1, 2024; 734 shares on January 1, 2025; 539 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 542 shares on January 1, 2026; and 234 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; with the final 240 shares on January 1, 2027, if he is an employee of the Company on those dates. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 21:54 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 904 | $85.86 | $77,617.44 |
DisclosureSEC source: 0001209191-22-056119 · doc4.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,067 F1 · price: The price reported is a weighted average price $85.86. The shares were purchased in multiple transactions at prices ranging from $85.83 to $85.88 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 7,067 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 911 shares on January 1, 2023; 734 shares on each of April 1, July 1 and October 1, 2023, and on January 1, 2024; 499 shares on each of April 1, July 1 and October 1, 2024; 500 shares on January 1, 2025; 305 shares on each of April 1, July 1 and October 1, 2025; and 308 shares on January 1, 2026, if he is an employee of the Company on those dates. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 14:52 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,808 | $90.43 | $163,497.44 |
DisclosureSEC source: 0001209191-22-045752 · doc4.xml · nonDerivative · entry 1 Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,971 F1 · price: The shares were sold in multiple transactions at prices ranging from $90.00 to $90.57 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 7,971 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 904 shares on October 1, 2022; 911 shares on January 1, 2023; 734 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2024; 499 shares on each of April 1, July 1 and October 1, 2024; 500 shares on January 1, 2025; 305 shares on each of April 1, July 1 and October 1, 2025; and the final 308 shares on January 1, 2026, if he is employed by the Company on those dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.